11474660

Source:http://linkedlifedata.com/resource/pubmed/id/11474660

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0009905, umls-concept:C0030563, umls-concept:C0035647, umls-concept:C0376571, umls-concept:C1140680, umls-concept:C1511024, umls-concept:C1742737
pubmed:issue	4
pubmed:dateCreated	2001-7-13
pubmed:abstractText	Multiparity and the use of oral contraceptives reduce the risk of ovarian cancer, but their effects on this risk in women with a BRCA1 or BRCA2 mutation are unclear.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/MS N02-CP-81005, http://linkedlifedata.com/resource/pubmed/grant/N02-CP-60534, http://linkedlifedata.com/resource/pubmed/grant/N02-CP-91026, http://linkedlifedata.com/resource/pubmed/grant/R01 CA61126-01-03
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0255562
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/BRCA2 Protein, http://linkedlifedata.com/resource/pubmed/chemical/Contraceptives, Oral, http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0028-4793
pubmed:author	pubmed-author:BellerUU, pubmed-author:Ben-BaruchGG, pubmed-author:ChetritAA, pubmed-author:FishmanAA, pubmed-author:HartgePP, pubmed-author:Hirsh-YechezkelGG, pubmed-author:LubinFF, pubmed-author:MenczerJJ, pubmed-author:ModanBB, pubmed-author:National Israel Ovarian Cancer Study Group, pubmed-author:StruewingJ PJP, pubmed-author:TuckerM AMA, pubmed-author:WacholderSS
pubmed:issnType	Print
pubmed:day	26
pubmed:volume	345
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	235-40
pubmed:dateRevised	2010-2-3
pubmed:meshHeading	pubmed-meshheading:11474660-Adult, pubmed-meshheading:11474660-Aged, pubmed-meshheading:11474660-BRCA2 Protein, pubmed-meshheading:11474660-Case-Control Studies, pubmed-meshheading:11474660-Contraceptives, Oral, pubmed-meshheading:11474660-Female, pubmed-meshheading:11474660-Genes, BRCA1, pubmed-meshheading:11474660-Germ-Line Mutation, pubmed-meshheading:11474660-Heterozygote, pubmed-meshheading:11474660-Humans, pubmed-meshheading:11474660-Jews, pubmed-meshheading:11474660-Logistic Models, pubmed-meshheading:11474660-Middle Aged, pubmed-meshheading:11474660-Mutation, pubmed-meshheading:11474660-Neoplasm Proteins, pubmed-meshheading:11474660-Ovarian Neoplasms, pubmed-meshheading:11474660-Parity, pubmed-meshheading:11474660-Risk, pubmed-meshheading:11474660-Transcription Factors
pubmed:year	2001
pubmed:articleTitle	Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation.
pubmed:affiliation	Department of Clinical Epidemiology, Chaim Sheba Medical Center, Tel-Hashomer, Israel. BModan@gertner.health.gov.il
pubmed:publicationType	Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, N.I.H., Extramural